ArticleLeukemia & lymphoma2023

Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selection.

Kurt S Bantilan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.